Melatonin and Diabetes: A Genuinely Complicated Relationship

Written by the Nuvirox Research Team

If you have diabetes or prediabetes, talk to your doctor before using melatonin. It can affect glucose metabolism, and the effect varies by individual, timing, and genetics. This article reviews published research and is not a substitute for personalized medical advice.

Key points

  • Melatonin and glucose control are linked through the same receptor (MTNR1B) that’s one of the strongest genetic risk factors for type 2 diabetes.
  • Taking melatonin — or having high natural melatonin — at the same time as eating can impair glucose tolerance, and the effect is worse in the roughly 1-in-3 people who carry a common risk variant.
  • This doesn’t mean melatonin is off-limits for everyone with diabetes, but it does mean timing matters and a doctor should be involved.

Short answer: melatonin and blood sugar interact in ways that are genuinely complicated, and for some people melatonin can worsen glucose control — especially when taken close to food. This is one of the more surprising findings in melatonin research. The same melatonin receptor that helps regulate your clock also sits on the insulin-producing cells of your pancreas, and a common variant in its gene is among the strongest known genetic risk factors for type 2 diabetes. That biology has real, measured consequences in human trials.

Melatonin + carbohydrates at the same time high melatonin (night / supplement) + carbs higher post-meal glucose Effect is stronger in the ~1-in-3 people carrying the MTNR1B G risk variant.

When melatonin is high and carbohydrates arrive at the same time — as with late eating or an evening dose taken with a snack — post-meal glucose tends to run higher, especially in MTNR1B risk-variant carriers.

Why is melatonin connected to blood sugar at all?

The link is the melatonin receptor MTNR1B. Genome-wide studies found that a common variant in the MTNR1B gene (rs10830963) predicts future type 2 diabetes and impaired early insulin secretion, and the receptor is expressed in the insulin-producing beta cells of the pancreas. When melatonin binds these receptors, it can suppress insulin release. So melatonin isn’t just a sleep signal — it’s also a message to your pancreas, and the timing of that message relative to food matters.

This is why “melatonin and diabetes” can’t be answered with a simple yes or no. The same molecule that helps your clock can blunt insulin secretion if it’s high when you eat.

What human studies actually show

Melatonin impaired glucose tolerance in controlled trials. In a study by Rubio-Sastre and colleagues, acute melatonin administration impaired glucose tolerance in healthy people, in both the morning and the evening. This established that melatonin doesn’t just correlate with glucose problems — it can causally worsen the glucose response in a controlled setting.

Genetics amplify the effect, and timing of food is central. In a randomized crossover trial of 845 people, late dinner timing — when natural melatonin was about 3.5-fold higher — produced lower insulin and higher glucose responses, and the effect was stronger in carriers of the MTNR1B G risk variant, traced to reduced beta-cell function. A separate controlled study found that melatonin worsened glucose and insulin responses specifically in risk-variant carriers and not significantly in non-carriers.

Study snapshot. 845 adults, randomized crossover · early vs late dinner (low vs high melatonin) · late timing: ~8.3% higher glucose AUC, ~6.7% lower insulin AUC; effect stronger in MTNR1B G-allele carriers via reduced beta-cell function.

Longer-term, the signal persisted in people with diabetes. A three-month randomized crossover trial reported that melatonin treatment reduced insulin sensitivity in patients with type 2 diabetes. The honest counterweight: not all data point one way. Some randomized trials using outcomes like HbA1c, fasting glucose, and fasting insulin have reported neutral or even beneficial effects, and melatonin’s antioxidant properties may help in specific diabetic complications. The overall picture is genuinely mixed — which is the point.

What this means in practice

A few practical implications follow from the research without overreaching. First, timing matters: taking melatonin right as you eat a carbohydrate-heavy snack is the scenario most likely to blunt your glucose handling. Second, genetics matter, and since roughly a third of people carry the risk variant — usually without knowing it — caution is reasonable. Third, none of this establishes that melatonin is dangerous for everyone with diabetes; it establishes that the interaction is real and individual. That combination is exactly why this belongs in a conversation with your doctor rather than a self-directed experiment.

What melatonin won’t do for diabetes

It won’t treat diabetes, lower your blood sugar as a therapy, or replace any part of a diabetes management plan — and you should be wary of anything marketed that way. It also won’t behave identically in everyone, so general reassurance (“it’s natural, it’s fine”) isn’t appropriate here. If you have diabetes or prediabetes and also struggle with sleep, that’s a worth-solving combination, but the solution should be designed with your clinician, who can weigh the glucose considerations against the sleep benefit.

There’s a practical wrinkle worth spelling out for anyone weighing this. The scenario that most consistently impairs glucose handling is melatonin being high at the same time as carbohydrate intake — which describes both late-night eating and the common habit of taking a melatonin gummy or tablet alongside a bedtime snack. Separating melatonin from food, and avoiding large late carbohydrate-heavy meals, is the kind of low-cost adjustment a clinician might suggest for someone who wants to use melatonin despite metabolic concerns.

Frequently asked questions

Is melatonin safe for diabetics?

It’s complicated and individual. Melatonin can impair glucose tolerance, especially near food and in people with a common genetic variant, but some trials show neutral effects on longer-term markers. Anyone with diabetes should clear it with their doctor.

Does melatonin raise blood sugar?

It can worsen the glucose response to food, particularly when melatonin is high at mealtime. The effect is stronger in MTNR1B risk-variant carriers. Effects on long-term markers like HbA1c are more mixed.

Should I take melatonin with a bedtime snack?

That’s the timing most likely to blunt glucose handling, because you’re combining high melatonin with carbohydrates. If you use melatonin, separating it from food is a reasonable precaution to discuss with your clinician.

What is the MTNR1B variant?

It’s a common variant in the melatonin-receptor gene, carried by roughly a third of people, that’s strongly linked to type 2 diabetes risk and to a larger glucose-impairing effect from melatonin. Most carriers don’t know their status.

Nuvirox Sleep+ Restore bottle

From Nuvirox

Why we formulated Sleep+ Restore

If you’re managing diabetes or prediabetes, melatonin’s effect on blood sugar is individual and timing-dependent — so check with your doctor before adding any melatonin product, including Sleep+ Restore. Sleep+ Restore combines melatonin with vitamin B6 and a botanical blend (L-theanine, lemon balm, passionflower, chamomile, ashwagandha, GABA)’so the formula doesn’t lean on melatonin to do all the work.

Every order is covered by a 60-day money-back guarantee’long enough to actually evaluate it the way the research says you should.

Learn more about Sleep+ Restore →

The bottom line

“Melatonin and diabetes” has no tidy answer. Melatonin acts on the same receptor that’s a major diabetes risk gene, and trials show it can impair glucose tolerance — most clearly near food and in the third of people carrying a common variant. Yet some longer-term studies are neutral. The takeaway isn’t fear; it’s that the interaction is real enough that anyone with diabetes should involve their doctor and pay attention to timing.

References

  1. Rubio-Sastre P, Scheer FA, Gomez-Abellan P, Madrid JA, Garaulet M. Acute melatonin administration in humans impairs glucose tolerance in both the morning and evening. Sleep. 2014;37(10):1715-1719. doi:10.5665/sleep.4088.
  2. Garaulet M, et al. Interplay of dinner timing and MTNR1B type 2 diabetes risk variant on glucose tolerance and insulin secretion: a randomized crossover trial. Diabetes Care. 2022;45(3):512-519. doi:10.2337/dc21-1314.
  3. Lyssenko V, et al. Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat Genet. 2009;41(1):82-88. PMC3725650.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.

Back to blog